We are live on ! Find out more
GF

Gates Foundation Portfolio holdings

AUM $43.5M
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
+17.49%
1 Year Est. Return
+14.19%
3 Year Est. Return
-58.08%
5 Year Est. Return
10 Year Est. Return
AUM
$43.5M
AUM Growth
+$3.28M
Cap. Flow
-$94.8K
Cap. Flow %
-0.22%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CVAC
CureVac
CVAC
+$94.8K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNTX icon
1
BioNTech
BNTX
$22.6B
$17.7M 40.59%
148,674
VIR icon
2
Vir Biotechnology
VIR
$1.47B
$11.7M 26.85%
1,559,142
EXAI
3
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$7.76M 17.85%
1,590,909
CVAC
4
DELISTED
CureVac
CVAC
$4.61M 10.6%
1,568,866
-28,771
-2% -$94.8K
BFLY icon
5
Butterfly Network
BFLY
$1.71B
$1.79M 4.11%
1,011,003

Similar funds

Gates Foundation's Q3 2024 Portfolio in Review

As of Q3 2024, Gates Foundation held 5 positions worth $43.5M, up 8.2% from $40.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 0%. Gates Foundation opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Gates Foundation's biggest Q3 2024 reduction was CureVac, cutting an estimated $94.8K.
  • Gates Foundation's ten largest holdings make up 100% of its $43.5M portfolio in Q3 2024.
  • Gates Foundation opened 0 new positions and closed 0 in Q3 2024.
  • Gates Foundation's portfolio value rose 8.2% quarter-over-quarter to $43.5M.

Based on Gates Foundation's 13F filing for Q3 2024, filed 14 Nov 2024.